Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: ghrelin receptor antagonists - COSCIENS Biopharma

Next Previous
X
Search
Drug Profile

Research programme: ghrelin receptor antagonists - COSCIENS Biopharma

Alternative Names: 1,2,4-Triazole based ghrelin receptor ligands as anti-obesity agents - COSCIENS Biopharma; AEZS-123; JMV 2760; JMV 2959; JMV 3018; JMV 3534

Latest Information Update: 08 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Zentaris
  • Developer AEterna Zentaris GmbH; AEterna Zentaris Inc; COSCIENS Biopharma; University of Milan; University of Montpellier I; University of Montpellier II; University of Montreal
  • Class Small molecules; Triazoles
  • Mechanism of Action Ghrelin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Alcoholism; Obesity

Most Recent Events

  • 06 Aug 2024 AEterna Zentaris Inc is now called COSCIENS Biopharma
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Obesity in Canada
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Obesity in France

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top